A Randomized Controlled Trial of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks Compared to Sofosbuvir with Ribavirin for 12 Weeks in Genotype 2 HCV-Infected Patients: The Phase 3 ASTRAL-2 Study

Press/Media: Press / Media

PeriodDec 1 2015

Media coverage

1

Media coverage

  • TitleA Randomized Controlled Trial of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks Compared to Sofosbuvir with Ribavirin for 12 Weeks in Genotype 2 HCV-Infected Patients: The Phase 3 ASTRAL-2 Study
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date12/1/15
    PersonsJing Wang, Eric J Lawitz
View all 1
View less